Sign in

NCT04156061Active, not recruiting

Effect of the SCOT-HEART 2 Trial on Lifestyle.

Effect of the SCOT-HEART 2 Trial on Lifestyle and Risk Factor Modification.

Source: ClinicalTrials.gov · Last updated 18 Nov 2025

Brief summary (registry, in English)

This study will recruit 400 participants who are taking part in the Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (SCOT-HEART 2) trial. The investigator will assess diet, activity and habits at the start of the study and 6 months later. This will help us understand the effects taking part in the study may have on lifestyle. In addition, for participants who have CT scans, the investigator will present the results of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to patients.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
400 (actual)
First submitted
1 Nov 2019
Start date
28 Sept 2020
Primary completion date
12 Jan 2024
Lead sponsor
University of Edinburgh
NCT number
NCT04156061

What you commit to

  • Study type: Interventional
  • Participants enrolled: 400
  • From 28 Sept 2020 to the primary completion date, 12 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Who the study is looking for

  • MUST BE ENROLLED IN SCOTHEART 2 TRIAL

Age in the registry: 40 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Edinburgh
Coordinator of this site? Confirm its status
EdinburghUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.